Login / Signup

A novel missense mutation in TFAP2B associated with Char syndrome and central diabetes insipidus.

Heather L EdwardAlissa M D'GamaMonica Hsiung WojcikCatherine A BrownsteinMargaret A KennaP Ellen GrantJoseph A MajzoubPankaj B Agrawal
Published in: American journal of medical genetics. Part A (2019)
Char syndrome is characterized by persistent patent ductus arteriosus (PDA) associated with hand-skeletal abnormalities and distinctive facial dysmorphism. Pathogenic variants in the transcription factor gene TFAP2B have been shown to cause Char syndrome; however, there is significant phenotypic variability linked to variant location. Here, we report a pediatric patient with a novel de novo variant in the fifth exon of TFAP2B, c.917C > T (p.Thr306Met), who presented with PDA, patent foramen ovale, postaxial polydactyly of the left fifth toe and clinodactyly of the left fourth toe, sensorineural hearing loss, scoliosis, dental anomalies, and central diabetes insipidus (CDI). CDI, scoliosis, and hearing loss have not previously been reported in a patient with Char syndrome, and while the association may be coincidental, this report expands the genotypes and potentially phenotypes associated with this syndrome.
Keyphrases
  • case report
  • type diabetes
  • transcription factor
  • cardiovascular disease
  • hearing loss
  • glycemic control
  • risk assessment
  • intellectual disability
  • insulin resistance